Literature DB >> 6814926

Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.

E A Fagan, R F Dyck, P N Maton, H J Hodgson, V S Chadwick, A Petrie, M B Pepys.   

Abstract

Prospective measurements were made of serum C-reactive protein levels and erythrocyte sedimentation rate in sixty-four patients with Crohn's disease and fifty with ulcerative colitis. The results were related to clinical assessment of disease activity. C-reactive protein levels were raised in both groups but were significantly higher in Crohn's disease than ulcerative colitis for all categories of disease severity: with mild disease the median and range of C-reactive protein concentration were 4, 0-65 mg/l in Crohn's disease v. 0, 0-15 mg/l in ulcerative colitis, P less than 0.01; in moderate disease the values were 15, 1-100 mg/l v. 3, 0-29 mg/l respectively, P less than 0.05 and in cases of severe disease, 85, 15-183 mg/l v. 12, 2-33 mg/l respectively, P less than 0.001. Erythrocyte sedimentation rate was also higher in Crohn's disease but did not closely reflect disease activity in individual patients. C-reactive protein levels corresponded closely with clinical and pathological indices of relapse, remission and response to therapy in patients with Crohn's disease. The precise assay of serum C-reactive protein provides an objective criterion of inflammatory activity, which may be useful in the assessment, management and study of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814926     DOI: 10.1111/j.1365-2362.1982.tb02244.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  81 in total

1.  Does plasma resistin level have a role in predicting inflammatory bowel disease activity?

Authors:  N A Abdel Kader; F A Ali El-Din; E A A Khatab; N E ELAbd
Journal:  Indian J Gastroenterol       Date:  2010-06

2.  Plasma leucocyte elastase concentrations in smokers.

Authors:  C R Hind; H Joyce; G A Tennent; M B Pepys; N B Pride
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

3.  Measurement of Fractional Exhaled Nitric Oxide as a Marker of Disease Activity in Inflammatory Bowel Disease.

Authors:  Erkanda Ikonomi; Robin D Rothstein; Adam C Ehrlich; Frank K Friedenberg
Journal:  J Gastroenterol Pancreatol Liver Disord       Date:  2016-01-27

4.  B1a lymphocytes in ulcerative colitis.

Authors:  Lino Polese; Giuseppe De Franchis; Marco Scarpa; Giacomo C Sturniolo; Cesare Ruffolo; Lorenzo Norberto; Mauro Frego; Davide F D'Amico; Imerio Angriman
Journal:  Int J Colorectal Dis       Date:  2007-03-20       Impact factor: 2.571

5.  Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.

Authors:  T Minami; H Tojo; Y Shinomura; S Tarui; M Okamoto
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

6.  European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

7.  Plasma viscosity in inflammatory bowel disease.

Authors:  A J Lobo; S C Jones; L D Juby; A T Axon
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

8.  Evaluation of disease activity in rheumatic patients by leucocyte adhesiveness/aggregation.

Authors:  S Berliner; M Fried; D Caspi; A Weinberger; M Yaron; J Pinkhas; M Aronson
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

9.  Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

10.  C-reactive protein and disease activity in children with Crohn's disease.

Authors:  Samantha Tilakaratne; Daniel A Lemberg; Steven T Leach; Andrew S Day
Journal:  Dig Dis Sci       Date:  2010-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.